Artificial intelligence for drug discovery and development

A new Pasteur International Joint Research Unit (PIU) has been set up between the Institut Pasteur and the Institut Pasteur Korea for the development of technologies that will help in the discovery of next-generation therapies to treat infectious diseases. The new structure, known as PIU Ai3D (Artificial intelligence for image-based drug discovery & development), is governed by an agreement signed by the two partner institutes.

Find out more